Abcam (ABCM US)

Analysis

Health Care • United Kingdom

Abcam is a global life science company that identifies, develops, and distributes reagents and tools for scientific research, diagnostics, and drug discovery. Its product portfolio includes primary and secondary antibodies, immunoassays, proteins, peptides, and edited cell lines. Abcam was founded in 1998 and is headquartered in Cambridge, UK.

Refresh

Exchange Announcement • 13 Jan 2024 00:40

US SEC Form SC 13G/A for Abcam plc

Exchange Announcement • 19 Dec 2023 05:17

US SEC Form 15-12G for Abcam plc

Exchange Announcement • 16 Dec 2023 05:24

US SEC Form S-8 POS for Abcam plc

Exchange Announcement • 16 Dec 2023 05:21

US SEC Form S-8 POS for Abcam plc

Exchange Announcement • 16 Dec 2023 05:18

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00